Results
1 -
10 of
17Neue Erkenntnisse zur Genetik der Schizophrenie, Der Nervenarzt Combined administration of an mGlu2/3 receptor agonist and a 5-HT2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants, Psychopharmacology Effects of a novel mGlu2/3 receptor agonist prodrug, LY2140023 monohydrate, on central monoamine turnover as determined in human and rat cerebrospinal fluid, Psychopharmacology mGlu2/3 Agonists u2013 a New Approach to the Treatment of Schizophrenia: Results of a Randomized Double-Blind Trial, Neuroscience and Behavioral Physiology Metabotropic Glutamate 2 (mGlu2) Receptors and Schizophrenia Treatment, mGLU Receptors mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia, Psychopharmacology A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia, BMC Psychiatry Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders, European Archives of Psychiatry and Clinical Neuroscience Targeting metabotropic glutamate receptors for novel treatments of schizophrenia, Molecular Brain